The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNPSN.L Regulatory News (NPSN)

  • There is currently no data for NPSN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

22 Jun 2021 16:50

RNS Number : 7449C
Naspers Limited
22 June 2021
 

Naspers Limited(Incorporated in the Republic of South Africa)(Registration number 1925/001431/06)JSE share code: NPN ISIN: ZAE000015889LSE ADS code: NPSN ISIN: US 6315122092(Naspers)

 

PROSUS N.V. ANNOUNCES COMPLETION OF THE NASPERS SHARE PURCHASE

Shareholders are referred to the announcement issued by Naspers's subsidiary Prosus N.V. (Prosus) on 23 November 2020 in respect of the launch of an on-market Naspers N ordinary share purchase programme of up to US$3.63 billion (the Share Purchase) by Prosus.

Originally driven by the regulatory requirement to provide weekly updates on Prosus ordinary shares N repurchased, Prosus decided to continue providing voluntary updates to Naspers shareholders on the Naspers N ordinary shares it purchased.

For the period between 14 June 2021 and 21 June 2021, Prosus purchased 572 542 Naspers N ordinary shares at an average price of ZAR3 030.2483 per share for a total consideration of ZAR1 734 944 430.51 (US$123 364 855.77). This concludes the Share Purchase component of the programme announced on 23 November 2020.

Since the commencement of the programme on 23 November 2020:

· A total of 11 874 493 Prosus ordinary shares N were purchased (representing c. 0.7309% of the issued Prosus ordinary shares N) for a total consideration of US$1.37bn excluding transaction costs, which represents an average cost of EUR94.97 per Prosus ordinary share N.

· A total of 15 992 042 Naspers N ordinary shares were purchased (representing c. 3.672% of the issued Naspers N ordinary shares) for a total consideration of US$3.63bn excluding transaction costs, which represents an average cost of ZAR3 317.96 per Naspers N ordinary share

 

Cape Town22 June 2021

Sponsor: Investec Bank Limited

Enquiries

 

Investor Enquiries

Eoin Ryan, Head of Investor Relations

 

+1 347-210-4305

Media Enquiries

Shamiela Letsoalo, Media Relations Director SA

+27 78 802 6310

 

 

About Naspers

 

Established in 1915, Naspers has transformed itself to become a global consumer internet company and one of the largest technology investors in the world. Through Prosus, the group operates and invests globally in markets with long-term growth potential, building leading consumer internet companies that empower people and enrich communities. Prosus has a listing on Euronext Amsterdam and a secondary listing on the Johannesburg Stock Exchange and Naspers is the majority owner of Prosus.

 

In South Africa, Naspers is one of the foremost investors in the technology sector and is committed to building its internet and ecommerce companies in the country. These include Takealot, Mr D Food, Superbalist, OLX, Autotrader, Property24 and PayU, in addition to Media24, South Africa's leading print and digital media business.

 

Naspers is also focused on stimulating South Africa's local tech sector through Naspers Foundry. This is a R1.4 billion investment targeting early stage technology companies in South Africa that seek to address big societal needs. To help address youth unemployment in impoverished communities, in 2019, Naspers launched Naspers Labs, a social impact programme for young, unemployed South Africans aged between 17 and 25. Located in low income, urban settings, Naspers Labs provide a structured development journey enabling young people to enter the economy.

 

Naspers has a primary listing on the Johannesburg Stock Exchange (NPN.SJ) and a secondary listing on the A2X Exchange (NPN.AJ) in South Africa, and has an ADR listing on the London Stock Exchange (LSE: NPSN).

 

For more information, please visit www.naspers.com.

 

Disclaimer

The information contained in this document may contain forward-looking statements, estimates and projections. Forward-looking statements involve all matters that are not historical and may be identified by the words "anticipate", "believe", "estimate", "expect", "intend", "may", "should", "will", "would" and similar expressions or their negatives, but the absence of these words does not necessarily mean that a statement is not forward-looking. These statements reflect Prosus's intentions, beliefs or current expectations, involve elements of subjective judgement and analysis and are based upon the best judgement of Prosus as of the date of this document, but could prove to be wrong. These statements are subject to change without notice and are based on a number of assumptions and entail known and unknown risks and uncertainties. Therefore, you should not rely on these forward-looking statements as a prediction of actual results.

Any forward-looking statements are made only as of the date of this document and neither Prosus nor any other person gives any undertaking, or is under any obligation, to update these forward-looking statements for events or circumstances that occur subsequent to the date of this document or to update or keep current any of the information contained herein, any changes in assumptions or changes in factors affecting these statements and this document is not a representation by Prosus or any other person that they will do so, except to the extent required by law.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFTMJTMTATBPB
Date   Source Headline
13th Jan 20229:30 amRNSIssue of Debt
11th Jan 20223:15 pmRNSTransaction in Own Shares
7th Jan 20227:00 amRNSDirector/PDMR Shareholding
4th Jan 20223:15 pmRNSTransaction in Own Shares
29th Dec 20217:00 amRNSTransaction in Own Shares
21st Dec 20213:15 pmRNSTransaction in Own Shares
20th Dec 20217:00 amRNSDirectorate Change
20th Dec 20217:00 amRNSDirectorate Change
14th Dec 20213:15 pmRNSTransaction in Own Shares
13th Dec 20213:15 pmRNSNotice of Intention to Delist ADSs from the LSE
7th Dec 20213:15 pmRNSTransaction in Own Shares
30th Nov 20213:15 pmRNSTransaction in Own Shares
25th Nov 20213:30 pmRNSTreasury Stock
23rd Nov 20213:15 pmRNSTransaction in Own Shares
22nd Nov 20217:00 amRNSHalf-year Report
22nd Nov 20217:00 amRNSHalf-year Report
16th Nov 20213:15 pmRNSTransaction in Own Shares
16th Nov 20217:00 amRNSTrading Statement
16th Nov 20217:00 amRNSTrading Statement
9th Nov 20213:15 pmRNSTransaction in Own Shares
2nd Nov 20213:15 pmRNSTransaction in Own Shares
26th Oct 20214:15 pmRNSTransaction in Own Shares
22nd Oct 20211:30 pmRNSClarificatory statement re dividend
21st Oct 20217:50 amRNSClarificatory statement re dividend
19th Oct 20214:15 pmRNSTransaction in Own Shares
12th Oct 20214:15 pmRNSTransaction in Own Shares
5th Oct 20214:15 pmRNSTransaction in Own Shares
4th Oct 20214:50 pmRNSStatement re Delivery Hero transaction
4th Oct 20214:50 pmRNSStatement re Delivery Hero transaction
1st Oct 20217:45 amRNSDirector/PDMR Shareholding
28th Sep 20214:15 pmRNSTransaction in Own Shares
21st Sep 20214:15 pmRNSTransaction in Own Shares
14th Sep 20214:30 pmRNSTransaction in Own Shares
7th Sep 20214:50 pmRNSTransaction in Own Shares
31st Aug 20214:50 pmRNSTransaction in Own Shares
31st Aug 20214:30 pmRNSDirector/PDMR Shareholding
31st Aug 20219:15 amRNSProsus increases stake in Delivery Hero
31st Aug 20219:15 amRNSProsus increases stake in Delivery Hero
31st Aug 20217:00 amRNSacquisition of 100% OF THE equity IN BillDesk
31st Aug 20217:00 amRNSacquisition of 100% OF THE equity IN BillDesk
26th Aug 20214:30 pmRNSDirectorate Change
26th Aug 20214:30 pmRNSDirectorate Change
25th Aug 20214:50 pmRNSAGM Statement
24th Aug 20214:50 pmRNSRESULTS OF ANNUAL GENERAL MEETING
23rd Aug 20217:30 amRNSProsus Share Repurchase Programme
23rd Aug 20217:30 amRNSShare Repurchase Programme
20th Aug 20214:45 pmRNSDirector/PDMR Shareholding
20th Aug 20214:45 pmRNSDirector/PDMR Shareholding
16th Aug 20217:00 amRNSSettlement Exchange Offer – AFM Notifications
16th Aug 20217:00 amRNSCapital Restructure and Exchange Offer Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.